PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Department of Applied Biological Sciences, Tokyo University of Science, Noda 278-8510, Japan.\', \'MAX BioPharma, Inc., 2870 Colorado Avenue, Santa Monica, CA 90404, USA.\', \'The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.\', \'AIDS Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.\', \'Laboratoire de Virologie Moléculaire, Institut National de la Transfusion Sanguine, 75739 Paris, France.\', \'Department of Virology III, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.\', \'Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.\', \'MIRAI, JST, Kawaguchi Center Building, 4-1-8 Honcho, Kawaguchi City, Saitama 332-0012, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 316310.3390/ijms22063163
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 33808940
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33808940>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33808940>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all